Mergers and acquisitions activity in the biotechnology sector may have been in a slumber for much of 2013, but that changed last Friday when Onyx Pharmaceuticals (NASDAQ:ONXX), a maker of cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback